DSIJ Mindshare

Stock in focus: Pharma company hits milestone with successful Phase I study of DRL_TC a tocilizumab biosimilar; get full story here!

The company offers a diverse portfolio of products and services, including APIs, generics, branded generics, biosimilars and over the counter medications.

Siddharth Mane 0 965 Article rating: 4.7

The company offers a diverse portfolio of products and services, including APIs, generics, branded generics, biosimilars and over-the-counter medications. With a history of scientific advancements and industry-first achievements, the company remains committed to investing in future business opportunities.

Overnight Digest: Stocks likely to be in focus on July 12

The top Nifty gainers made up of Eicher Motors, ONGC, Tata Steel, M&M and Dr Reddy's Labs while Bharti Airtel, TCS, HCL Technologies, BPCL and Infosys were among the biggest losers.

Shreya Chaware 0 1415 Article rating: 4.0

On Monday, the Indian equity markets kept an eye on the quarterly results. The weak start of IT earnings lowered the sentiments which made benchmark indices start the session on  a negative note. 

Pharma stocks outperform; Dr Reddys Laboratories emerges as top BSE Sensex gainer

On the sectoral front, indices traded with modest gains with the pharma sector outperforming

Shreya Chaware 0 715 Article rating: 5.0

In the first hour of the trading session, Sensex and Nifty were able to recover some of the opening losses and traded flat. At the time of market opening, 27 out of 30 stocks on Sensex were trading in the red. The top gainers on Sensex are Dr Reddy’s Laboratories, Reliance Industries, and Maruti Suzuki whereas the top losers include Asian Paints, Tata Steel, Power Grid Corporation, L&T, and UltraTech Cement.  

RSS
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR